3719 Results

People

  1. Hudis
    Hudis
  2. Lee
    Lee
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Barakat
    Barakat
  6. Scher
    Scher
  7. Ladanyi
    Ladanyi
  8. Levine
    Levine
  9. Chi
    Chi
  10. DeMatteo
    DeMatteo

Groups

  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)
  7. Center for Hematologic Malignancies (503)
  8. Department of Pathology and Laboratory Medicine (470)
  9. Population Sciences Research Program (431)
  10. Epidemiology and Biostatistics (426)
  1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective study of tumor suppressor gene (TSG) methylation as a prognostic biomarker in surgically resected non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Drilon, A. E. D.; Sugita, H.; Sima, C. S.; Huang, E.; Danenberg, P. V.; Kris, M. G.; Rusch, V. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Design of a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2/neu, in patients with surgically resected urothelial cancer at high risk of recurrence
    Meeting Abstract

    Bajorin, D. F.; Sharma, P.; Sims, R. B.; Sandler, A.; Lerner, S. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • EGFR exon 20 insertion mutations: Incidence and clinicopathologic characteristics in US patients with lung adenocarcinoma
    Meeting Abstract

    Arcila, M. E.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • An updated safety analysis of OCEANS, a randomized, double-blind, phase III trial of gemcitabine (G) and carboplatin (C) with bevacizumab (BV) or placebo (PL) followed by BV or PL to disease progression (PD) in patients with platinum-sensitive (Plat-S) recurrent ovarian cancer
    Meeting Abstract

    Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Nycum, L. R.; Sovak, M. A.; Yi, J.; Husain, A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Incidence of benign versus malignant renal tumors in selected studies
    Meeting Abstract

    Russo, P.; Uzzo, R. G.; Lowrance, W. T.; Asnis-Alibozek, A.; LaFrance, N. D.; Libertino, J. A.; Pryma, D. A.; Divgi, C. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab (IPI) in metastatic castrate-resistant prostate cancer (mCRPC): Results from an open-label, multicenter phase I/II study
    Meeting Abstract

    Slovin, S. F.; Hamid, O.; Tejwani, S.; Higano, C. S.; Harzstark, A.; Alumkal, J. J.; Scher, H. I.; Chin, K. M.; Gagnier, P.; McHenry, M. B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Muller, S.; Fleisher, M.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Clinical outcomes with high-dose image guided radiotherapy (IGRT) compared with non-IGRT for the treatment of clinically localized prostate cancer
    Meeting Abstract

    Zelefsky, M. J.; Kollmeier, M.; Cox, B. W.; Pei, X.; Hunt, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Hamilton, R. J.; Joseph, V.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Gallagher, D. J.; Pendse, D.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Effect of MDV3100, an androgen receptor signaling inhibitor (ARSI), on overall survival in patients with prostate cancer postdocetaxel: Results from the phase III AFFIRM study
    Meeting Abstract

    Scher, H. I.; Fizazi, K.; Saad, F.; Taplin, M. E.; Sternberg, C. N.; Miller, K.; De Wit, R.; Mulders, P.; Hirmand, M.; Selby, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save